Literature DB >> 9765500

Mapping the prion protein using recombinant antibodies.

R A Williamson1, D Peretz, C Pinilla, H Ball, R B Bastidas, R Rozenshteyn, R A Houghten, S B Prusiner, D R Burton.   

Abstract

The fundamental event in prion disease is thought to be the posttranslational conversion of the cellular prion protein (PrPC) into a pathogenic isoform (PrPSc). The occurrence of PrPC on the cell surface and PrPSc in amyloid plaques in situ or in aggregates following purification complicates the study of the molecular events that underlie the disease process. Monoclonal antibodies are highly sensitive probes of protein conformation which can be used under these conditions. Here, we report the rescue of a diverse panel of 19 PrP-specific recombinant monoclonal antibodies from phage display libraries prepared from PrP deficient (Prnp0/0) mice immunized with infectious prions either in the form of rods or PrP 27-30 dispersed into liposomes. The antibodies recognize a number of distinct linear and discontinuous epitopes that are presented to a varying degree on different PrP preparations. The epitope reactivity of the recombinant PrP(90-231) molecule was almost indistinguishable from that of PrPC on the cell surface, validating the importance of detailed structural studies on the recombinant molecule. Only one epitope region at the C terminus of PrP was well presented on both PrPC and PrPSc, while epitopes associated with most of the antibodies in the panel were present on PrPC but absent from PrPSc.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765500      PMCID: PMC110372     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform.

Authors:  D Peretz; R A Williamson; Y Matsunaga; H Serban; C Pinilla; R B Bastidas; R Rozenshteyn; T L James; R A Houghten; F E Cohen; S B Prusiner; D R Burton
Journal:  J Mol Biol       Date:  1997-10-31       Impact factor: 5.469

2.  Recombinant scrapie-like prion protein of 106 amino acids is soluble.

Authors:  T Muramoto; M Scott; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

3.  Monoclonal antibodies to the cellular and scrapie prion proteins.

Authors:  R A Barry; S B Prusiner
Journal:  J Infect Dis       Date:  1986-09       Impact factor: 5.226

4.  Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform.

Authors:  T L James; H Liu; N B Ulyanov; S Farr-Jones; H Zhang; D G Donne; K Kaneko; D Groth; I Mehlhorn; S B Prusiner; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

5.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

6.  NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231).

Authors:  R Riek; S Hornemann; G Wider; R Glockshuber; K Wüthrich
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

7.  NMR structure of the mouse prion protein domain PrP(121-231).

Authors:  R Riek; S Hornemann; G Wider; M Billeter; R Glockshuber; K Wüthrich
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

8.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible.

Authors:  D G Donne; J H Viles; D Groth; I Mehlhorn; T L James; F E Cohen; S B Prusiner; P E Wright; H J Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

9.  Purified prion proteins and scrapie infectivity copartition into liposomes.

Authors:  R Gabizon; M P McKinley; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

10.  Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies.

Authors:  C L Masters; D C Gajdusek; C J Gibbs
Journal:  Brain       Date:  1981-09       Impact factor: 13.501

View more
  96 in total

1.  Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form.

Authors:  E Leclerc; D Peretz; H Ball; H Sakurai; G Legname; A Serban; S B Prusiner; D R Burton; R A Williamson
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Structural studies of the scrapie prion protein by electron crystallography.

Authors:  Holger Wille; Melissa D Michelitsch; Vincent Guenebaut; Surachai Supattapone; Ana Serban; Fred E Cohen; David A Agard; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

3.  Grand ideas floating freely. Conference on the new prion biology: basic science, diagnosis and therapy.

Authors:  Bruce Chesebro
Journal:  EMBO Rep       Date:  2002-12       Impact factor: 8.807

4.  Conformation-dependent high-affinity monoclonal antibodies to prion proteins.

Authors:  Larry H Stanker; Ana V Serban; Elisa Cleveland; Robert Hnasko; Azucena Lemus; Jiri Safar; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

5.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

6.  Abrogation of complex glycosylation by swainsonine results in strain- and cell-specific inhibition of prion replication.

Authors:  Shawn Browning; Christopher A Baker; Emery Smith; Sukhvir P Mahal; Maria E Herva; Cheryl A Demczyk; Jiali Li; Charles Weissmann
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

7.  Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease.

Authors:  Roger S Armen; Mari L DeMarco; Darwin O V Alonso; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

8.  From conversion to aggregation: protofibril formation of the prion protein.

Authors:  Mari L DeMarco; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

9.  Direct evidence of generation and accumulation of β-sheet-rich prion protein in scrapie-infected neuroblastoma cells with human IgG1 antibody specific for β-form prion protein.

Authors:  Toshiya Kubota; Yuta Hamazoe; Shuhei Hashiguchi; Daisuke Ishibashi; Kazuyuki Akasaka; Noriyuki Nishida; Shigeru Katamine; Suehiro Sakaguchi; Ryota Kuroki; Toshihiro Nakashima; Kazuhisa Sugimura
Journal:  J Biol Chem       Date:  2012-02-22       Impact factor: 5.157

10.  Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

Authors:  M B Zwick; A F Labrijn; M Wang; C Spenlehauer; E O Saphire; J M Binley; J P Moore; G Stiegler; H Katinger; D R Burton; P W Parren
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.